Intent: Sharing concerns about the impact of the US EU Trade situation on PepsiCo's business in Ireland.
Details: US EU Trade Negotiations
Intent: Discussion and sharing of information relating to the geopolitical situation, specifically concerns surrounding the imposition of trade tariffs by the US. Understanding of the industry case for altering Ireland's position in the European Council relating to the GPL, as well as raising potential subjects for Ireland's EU Presidency agenda.
Details: IPHA Delegation to meet with An Tánaiste on EU health legislation and policy matters (including GPL and Ireland's EU Presidency), as well as the domestic issue of the negotiation of the pricing and supply agreement.
Intent: Raise awareness about Explorium’s visitor numbers in its first year of reopening, outline new programmes and initiatives planned in the coming months, and highlight Explorium’s potential as a national resource.
Details: Letter to request meeting to discuss Explorium’s positive role in science education for children and young people and to highlight Explorium's potential as a national resource.
Intent: Inform on the implications for Irish supply chains of a proposed EU restrictions on the export of certain products
Details: Ibec information on impact of proposed EU export restrictions on certain products to the US
Intent: Activity in relation to Scale Ireland's Budget Proposals For 2026
Details: Budget 2026
Intent: Raise awareness of and discuss the challenges facing the aircraft leasing industry from possible EU tariffs on US imported aircraft and aircraft parts.
Details: Proposed EU countermeasures to US tariffs
Intent: Seeking Irish Government, working alongside the EU Commission, EU Member States work towards “zero for zero” treatment for medtech in EU/US Trade Deal.
Details: Supporting a “zero for zero” EU-US tariff agreement in the medical technology sector
Intent: Refrain from adopting tariffs or other commercial policy measures on imports of medical technologies from the United States.
Details: US Tariffs and EU Retaliatory Tariffs: Impact on healthcare in Europe
Intent: To highlight our concerns about the inclusion of pharmaceuticals in tariffs, the timing for entry into force, and the need for a zero-tariff pathway that includes innovative medicines. ::To highlight the potential impact of Most Favoured Nation pricing for pharmaceuticals in the US and the need for further investment in innovative medicines in Europe that recognises the value of biopharmaceutical innovation
Details: Raise concern about the impact of potential tariffs and related geo-political issues related to the pharmaceutical industry and pricing of medicines globally
Intent: To ensure awareness of business impact of US tariffs, and Irish and EU response
Details: Impact of US tariffs and Irish and EU response
